
    
      Chemotherapy will be given in accordance with local or regional guidelines but shall include
      a platinum drug + any topoisomerase inhibitor. Within these limits the study will accept
      different local variants as long as each centre remains consistent to its declared standard
      chemotherapy regimen. The recommended regimen is carboplatin or cisplatin plus etoposide q3
      weeks for 4 cycles but up to 6 cycles is allowed. Local dosages and dose reduction schedules
      will be used.
    
  